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Alzheimer, a neurodegenerative disease, and a large
variety of pathologic conditions are associated with a
form of protein aggregation known as amyloid ﬁbrils.
Since ﬁbrils and preﬁbrillar intermediates are cyto-
toxic, numerous attempts have been made to inhibit
ﬁbrillation process as a therapeutic strategy. Peptides,
surfactants and aromatic small molecules have been
used as ﬁbrillation inhibitors. Here we studied the ef-
fects of paclitaxel, a polyphenol with a high tendency
for interaction with proteins, on ﬁbrillation of insulin as
a model protein. The effects of paclitaxel on insulin
ﬁbrillation were determined by Thioﬂavin T ﬂuores-
cence, Congo red absorbance, circular dichroism and
atomic force microscopy. These studies indicated that
paclitaxel considerably hindered nucleation, and there-
fore, ﬁbrillation of insulin in a dose-dependant manner.
The isothermal titration calorimetry studies showed
that the interaction between paclitaxel and insulin
was spontaneous. In addition, the van der Waal’s inter-
actions and hydrogen bonds were prominent forces con-
tributing to this interaction. Computational results
using molecular dynamic simulations and docking stu-
dies revealed that paclitaxel diminished the polarity of
insulin dimer and electrostatic interactions by increas-
ing the hydrophobicity of its dimer state. Furthermore,
paclitaxel reduced disrupting effects of insulin ﬁbrils on
PC12 cell’s neurite outgrowth and complexity, and
enhanced their survival.
Keywords: cytotoxicity/inhibition/insulin ﬁbrillation/
nucleation/paclitaxel.
Abbreviations: AFM, atomic force microscope;
DMEM, Dulbecco’s modiﬁed Eagle’s medium; ITC,
isothermal titration calorimetry; MTT,
3-[4, 5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium
bromide; ThT, Thioﬂavin T.
It is a natural tendency of proteins to be misfolded
with disruption of their native conformation. Among
misfolded proteins a group of similar structural de-
posits named amyloid ﬁbrils tend to aggregate with
some particular traits, either systemically or locally in
certain organs or tissues, and cause amyloidosis (1, 2).
Long and un-branched ﬁlaments sharing a cross-b
structure are particularly attributed to ﬁbril compo-
nents of amyloid diseases (15). Alzheimer’s disease,
type II diabetes, insulin-related amyloidosis, lysozyme
amyloidosis and the majority of the amyloid diseases
are evidently associated with debilitating conditions
and aging (2). Recently, development of in vitro
model systems to study amyloid formation, and its de-
tailed structural, kinetic and thermodynamic charac-
teristics has become widely possible. In the case of
globular proteins, amyloid forms are produced under
denaturing conditions (6, 7).
The toxicity of amyloid aggregates is an inherent
characteristic, which is correlated with common struc-
tural backbone and not with speciﬁc tracks of residues
(8). Thus, many efforts are being made to ﬁnd suitable
solutions to inhibit ﬁbril formation. Surfactants (9),
peptides (10), small molecules (11, 12), nanoparticles
(13), polyphenols (1416) and even glycation (17) are
considered for their possible inhibitory effects. Among
these, the natural and synthetic polyphenols have
shown a great tendency to inhibit amyloid ﬁbril for-
mation (14). The Polyphenol’s inhibitory effects have
been observed with different amyloidogenic proteins
in vitro, in cell culture and in vivo (16, 18).
Paclitaxel (Taxol) is a complex diterpene isolated
from Taxus brevifolia. Due to its ability to bind and
stabilize the cytoplasmic microtubules (1921), and
thus block the cell cycle in G2 and M phase, paclitaxel
has become an important antimitotic and antitumour
agent (22). It has been also reported that there is a func-
tional taxoid-binding site on tubulin dimers (23, 24).
Paclitaxel is also clinically used for the treatment of
refractory ovarian cancer and many other tumour
types including lung, breast, prostate, and head and
neck cancer (25). Microtubule stabilizing agents have
also been suggested for use against Alzheimer-type
neuropathogenesis, since they could protect neurons
against b-amyloid toxicity (26). Aromatic rings in the
structure of paclitaxel suggest that paclitaxel may
J. Biochem. 2014;113 doi:10.1093/jb/mvu012
 The Authors 2014. Published by Oxford University Press on behalf of the Japanese Biochemical Society. All rights reserved 1
 Journal of Biochemistry Advance Access published March 24, 2014
 at N
ational Chung H
sing U
niversity Library on A
pril 11, 2014
http://jb.oxfordjournals.org/
D
ow
nloaded from
 
inhibit amyloid formation through the effects of its
aromatic interactions.
Insulin is a small globular protein with a molecular
weight of approximately 5,783Da, and is consist of
two helical chains linked together by two disulﬁde
bonds (27, 28). In the laboratory and under conditions
like high temperature, high concentration and low pH
which cause partially unfolded intermediates, insulin
molecules undergo the process of ﬁbrillation (2932).
In some studies, insulin ﬁbrillar forms and preﬁbrillar
intermediates have shown cytotoxicity on rat pheo-
chromocytoma PC12 (9, 33) and pancreatic b-cells
(34). It seems that insulin ﬁbrillation initiates with
the partial unfolding of the monomers, followed by
further association into protein oligomers, and ﬁnally
formation of mature amyloid aggregates (30, 35).
Bovine insulin is one of the best-characterized proteins,
and used in many studies including assessment of its
three-dimensional structure, foldingunfolding mech-
anisms, unfolding intermediates and stability informa-
tion (36). Thus, insulin is a suitable model to explore
protein ﬁbrillation.
In the present study, we explored insulin ﬁbrillation
under acidic pH and high temperature, and determined
the effects of paclitaxel on this process. Moreover, in
order to deliberate how and by what mechanisms
paclitaxel interacts with insulin, isothermal calorimetry
and docking simulation were performed. In our previ-
ous study, we explored the surface properties of ﬁbril-
lar insulin and its intermediates, and found the
association of this characteristic with cytotoxicity be-
cause of detergent-like effect of them, especially for
oligomeric forms. The aim of this work was to study
the interaction of paclitaxel, as a polyphenol small
molecule, with insulin and its high potency for inhib-
ition of insulin amyloid ﬁbrillation. This criterion was
considered based on paclitaxel high tendency to inter-
act with proteins. Here, the ﬁbrillar form of insulin has
just been studied. Finally, the impact of insulin ﬁbrils
incubated with paclitaxel on neuronal-like PC12 cell
differentiation was investigated by considering neurite
outgrowth and complexity criteria, cell viability and
apoptosis, as a complementary study to better illus-
trate the modulating effect of paclitaxel on insulin
amyloid ﬁbrillation and cytotoxicity.
Experimental Procedures
Chemical
Bovine pancreas insulin (code I5500), ThT, Congo red, MTT (3-[4,
5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide), nerve
growth factor (NGF) and Dulbecco’s modiﬁed Eagle’s medium
(DMEM) were purchased from Sigma-Aldrich (St. Louis, MO,
USA). Horse serum and fetal bovine serum were obtained from
Life Technologies (Carlsbad, CA, USA). Paclitaxel (taxol) pur-
chased from Stragen (Switzerland). Sodium phosphate was from
Merck (Germany).
Sample preparation
Insulin powder was dissolved in aqueous HCl solution (pH 2.0) and
insulin concentration was determined by measuring absorbance at
276 nm with excitation coefﬁcients of 1mg/ml using an UV-3100
Shimadzu UV-Vis-NIR spectrophotometer (Japan). The pH of the
solution was adjusted to 1.6 prior to incubation. Fibrils were
prepared by incubating insulin solution (500 mM) at 57C. For in-
hibition studies, paclitaxel was diluted with aqueous HCl solution
(pH 2.0) and added to insulin solution in amounts that kept insulin
concentration constant with ratios of 1:1000, 1:100 and 1:10
(paclitaxel:insulin; P:I).
Congo red absorbance
The Congo red solution (20mM) was prepared by dissolving Congo
red powder in 25mM sodium phosphate buffer (pH 6.0). Following
incubation, 24 ml of each sample (insulin was diluted 6-fold) was
mixed with 176 ml of Congo red and incubated for 10min at room
temperature in the dark. Using a quartz cell with 1 cm path length
and a UV-Vis-NIR spectrophotometer (model UV-3100, Shimadzu,
Japan), absorbance spectrum of each protein sample was recorded
from 400 to 700 nm. Each spectrum is the average of three independ-
ent measurements.
ThT assay
Thioﬂavin T (ThT) assay is a useful ﬂuorometric method for deter-
mination of amyloid ﬁbrils in vitro (37). ThT was dissolved in 25mM
sodium phosphate buffer (pH 6.0) by vortexing and passed through
a 0.4 mm ﬁlter. ThT concentration was determined by measuring
absorbance at 416 nm with a molar extinction coefﬁcient of
26,600M1 cm1(10). At different time intervals, an aliquot (10 ml
for insulin) was diluted with ThT solution (20 mM) to 500ml.
Fluorescence measurements were conducted using Cary Eclipse
ﬂuorescence spectrophotometer (Varian, Australia) in a quartz cu-
vette with 1 cm path length. The excitation and emission wavelengths
were adjusted at 440 nm and 485 nm, respectively, with 5 nm slit
width for both. According to Nielsen et al. study (38), the acquired
data from ThT ﬂuorescence measurements were ﬁtted to the sigmoid
curve represented by the pursuant equation:
F ¼ Fmin þ Fmax
1þ e½ðtt0Þ= ,
whereas F is ﬂuorescence intensity, the incubation time is t and t0 is
the time to obtain 50% of maximal ﬂuorescence. Thus, using the
acquired value of t by nonlinear regression, the apparent growth rate
constant of ﬁbrils and lag phase were deﬁned by 1/t and t0 2t,
respectively. Each point is the average of three independent
measurements.
Circular dichroism spectroscopy
Secondary structure analysing was done using Far-UV-CD. Insulin
samples were diluted 6-fold with aqueous HCl (pH 2.0) in a quartz
cell with a 1mm path length. Using a spectropolarimeter (model
J-810, Jasco, Japan) the CD spectra was recorded by scanning
the sample from 195 to 260 nm at the ambient temperature.
Bandwidth of 1 nm, slit width of 0.02mm and speed of 50 nm s1
was considered for each scanning. Each spectrum is the average
of ﬁve scan and CD spectra of aqueous HCl was subtracted from
insulin spectra.
Atomic forcemicroscopy
Fibrillar structure of insulin was visualized using atomic force mi-
croscopy. An aliquot (10 ml) of incubated solution was diluted 300-
fold in aqueous HCl (pH 2.0) and 10 ml of diluted sample was placed
on lamella (freshly washed with distilled water and alcohol) and
dried at room temperature. Images were acquired in non-contact
mode with a loop ﬁlter of 2Hz and force of 5.522.5N/m. Each
scan was done in a 55 mm2 area, using an AFM (Autoprobe CP
research, Veeco, USA) and conical shape silicon tip with resonance
frequency of 190325 kHz. The analysis of images was performed
using ‘ProScan 1.7’ software. For determining diameter and height
of particles 10 particles in each image were selected randomly, then
the average and standard deviation were calculated.
Isothermal titration calorimetry
In order to explore the interaction of paclitaxel with insulin, isother-
mal titration calorimetry (ITC) technique was used with a VP-ITC
(Microcal, USA). All solutions (buffer, insulin and paclitaxel) were
degassed at 25C while stirring, before experiment. Stirring of insulin
was done in low rate and paclitaxel was done in high rate for 3min
using thermovac (sample degassing and thermostat). The sample and
reference cell were ﬁlled with 1.8ml of insulin (15 mM) and 1.8ml of
buffer (aqueous HCl, pH 1.6), respectively. Each cell was coin
shaped and adiabatic. The syringe was ﬁlled with 300ml of paclitaxel
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(150 mM) which was injected into the sample cell in 30 steps. In the
ﬁrst step 5 ml of paclitaxel in the period of 10 s, and the other steps
10 ml in the period of 20 s were injected. The heat exchange was
recorded using Microcal ORIGIN software (v.7.0), once for inter-
action of paclitaxel with insulin and once for dilution of insulin.
Then dilution heat was subtracted from interaction heat, the
acquired curves were ﬁtted in one set of site model, and thermo-
dynamic parameters including number of sites (N), afﬁnity constant
(K), enthalpy (H) and entropy (S) changes were obtained by
frequent curve ﬁtting of binding isotherms using Origin 7. The
Gibbs free energy (G) change was calculated from following equa-
tion (G¼HTDS).
Computational approaches
The 3D structure of paclitaxel and insulin are reﬁned by short MD
after energy minimization in aqueous condition. The docking com-
putation was performed by HEX 6. The best results (based on bind-
ing energy) of docking output was analysed in VMD software. Swiss
PDB viewer program was utilized to compute electrostatic potential
of molecules.
Cell culture and PC12 cells differentiation
Rat pheochromocytoma (PC12) cells were obtained from Pasteur
Institute (Tehran, Iran). The cells were grown in DMEM containing
5% fetal bovine serum, 10% horse serum, and 1% penicil-
linstreptomycin at 37C and 5% CO2. To induce differentiation,
PC12 cells were incubated with NGF (50 ng/ml) every other day for
6 days. Growth medium was changed three times a week.
Treatment conditions andmorphological determination
of PC12 cells
Differentiated PC12 cells, seeded in 6-well plates, were pre-incubated
with paclitaxel (50 mM) 2h prior to initiation of the experiments. The
cells were then incubated with 25 mM of insulin ﬁbrils (incubated for
420min, with concentration of 500mM; prepared in the absence or
the presence of different concentrations of paclitaxel 0.5, 5 and
50 mM) for 2, 5, 8 and 12 h. For morphological analysis, two
random images were acquired from each well by phase contrast
microscopy (Olympus IX71, Japan). A minimum of 50 cells per
treatment were quantiﬁed. The cell body was the criteria for selec-
tion. The cell processes were completely within the ﬁeld of view, and
the body of an individual cell was distinct from neighbouring cells.
Cells ﬁtting these criteria were analysed and their cell body area,
average neurite length, neurite width, and the number of primary
neurites and bipolar morphology were quantiﬁed.
Cell body area was deﬁned as the area of the cell that neurite
processes originate from and contained cell organelles. Neurite
length was calculated by summing the lengths of the primary pro-
cesses and all associated branches. To establish the average neurite
width, the outlines of individual primary neurites were traced. The
cell body area was calculated by Cell A software and then divided by
the length of the neurites. Primary neurites were deﬁned as clear
protrusions from the cell body that are greater than 10 mm in
length. Cells were considered ‘bipolar’ if they displayed a cell body
with one process at each end. To evaluate neurite networks, images
were analysed using the cell counter plug-in to score all branching
nodes in each image. Nodes were deﬁned as sites where individual
neurites branched or separate neurites contacted each other. All
measurements were expressed as proportions of cells displaying the
characteristics of a sub-population of the total number of cells which
met the selection criteria described above. A sample of this process-
ing is shown in Fig. 7A.
MeasurementofcellviabilityemployingMTTassayandHoechst
staining
Conventional MTT reduction assay was utilized to determine cell
viability. The live cells turned dark blue because of formation of
formazan crystals from mitochondrial oxidation. Dimethyl sulfoxide
(DMSO) was used to solubilize the coloured crystals and the absorb-
ance was measured at 550 nm. The percentage of cell viability was
determined as the percentage of reduced MTT, considering the ab-
sorbance of control cells as 100%.
Hoechst 33342 (Invitrogen, H3570) staining as a criteria for de-
tection of apoptotic cells was also conducted. Differentiated PC12
cells were cultured in a 96-well plate and were incubated with insulin
ﬁbrils prepared without or with 50 mM paclitaxel for different times.
Cells were harvested at appropriate times and washed three times
with phosphate buffer saline. The cells were then incubated for 5min
at room temperature with Hoechst 33342 (1 mg/ml) and nuclei were
visualized using ﬂuorescence microscopy (Olympus).
Statistical analysis
All experiments were conducted at least three times and the ﬁnal
data are represented as the meanS.E.M. Comparison between
groups was made by one-way analysis of variance (ANOVA) fol-
lowed by a speciﬁc post hoc test to analyse the difference. Mean
differences were considered signiﬁcant when p50.05 (*or #p50.05,
**or ##p50.01 and ***p or ###p50.001).
Results
Paclitaxel reduces formation of beta-sheet structures
and delays nucleation of insulin
Congo red and ThT are markers for recognition of
beta-sheet structures (39). Fig. 1A shows no consider-
able differences, before incubation, between the Congo
red spectra of insulin alone or with different concen-
trations of paclitaxel compared to Congo red spec-
trum. Following incubation, a signiﬁcant increase in
Congo red absorbance and a red shift to 540 nm was
observed for insulin compared with the native form.
However, in the presence of paclitaxel the trends of
Congo red absorbance were very different. At lower
concentration of paclitaxel (0.5 mM with a ratio of
1:1000, P:I), absorbance intensity and red shift
decreased a little, but at higher concentration of pacli-
taxel (50 mM with ratio of 1:10, P:I) absorbance spec-
trum intensity of Congo red was signiﬁcantly
decreased and the red shift diminished compared
with control. Thus, the Congo red spectrum of insulin
in the presence of paclitaxel was similar to the native
form.
The kinetic of ﬁbrillation was acquired using ThT
ﬂuorescence emission at 485 nm. These results showed
that ﬁbrillation of insulin had a three state sigmoid
proﬁle including: a lag phase, elongation phase and
saturation phase. Fig. 1B shows the trends of insulin
ﬁbrillation in the presence and absence of paclitaxel. In
low concentration of paclitaxel with ratio 1:1000 (P: I),
an increase in lag phase was observable in insulin ﬁb-
rillation. However, with an increase in elongation rate,
ﬁbrillation process reached a plateau. There was no
signiﬁcant change in saturation phase intensity of in-
sulin ﬁbrillation. With increased paclitaxel concentra-
tion, the lag phase increased directly, and the
saturation phase occurred to a lower extent compared
to control indicating that the formation of ﬁbrils was
reduced.
The extent of alterations in the lag phase and max-
imum ﬁbrillation was most evident when insulin was
pre-incubated with 50 mM of paclitaxel. Alterations in
the kinetic parameters including lag phase and growth
rate of ﬁbrillation were affected by various concentra-
tions of paclitaxel and are summarized in Table I. With
increased paclitaxel concentration up to 50 mM, the lag
phase and growth rate of ﬁbrillation were increased,
and the ratio of ﬁbril formation was decreased to 38%.
In order to explore the efﬁcacy of paclitaxel on
elongation phase, 20 mM of ﬁbrils which it had been
prepared already, were added to insulin solutions
(without and with paclitaxel) before incubation. As it
Paclitaxel inhibits insulin fibrillar toxicity
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was shown in Fig. 1C, ﬁbrillation is commenced at the
onset of incubation and presence of paclitaxel in dif-
ferent concentrations (0.5, 5 and 50 mM) did not im-
press the process of insulin ﬁbrillation. This study
indicates that paclitaxel did not affect on elongation
phase of insulin ﬁbrillation.
Stabilization of insulin secondary structure in the
presence of paclitaxel
Secondary structure analysis of insulin with circular
dichroism before incubation showed two minima
around 208 and 222 nm, which indicated the dominant
alpha secondary structure of insulin (29). In addition,
the presence of different concentrations of paclitaxel in
insulin solutions did not result in secondary structure
changes (Fig. 2A). Following incubation, the former
minima were vanished, and another minimum ap-
peared around 216 nm, which is a characteristic of
beta-sheet secondary structure. In the presence of
increasing concentration of paclitaxel signiﬁcant differ-
ences were observed in the insulin secondary structure.
In 0.5mM paclitaxel (with ratio of 1:1000, P:I), the
secondary structure of insulin did not change signiﬁ-
cantly compared with no paclitaxel. Samples which
were incubated with 5 mM and 50 mM paclitaxel
(ratios of 1:100 and 1:10, P:I) showed a dramatic
change in CD spectra, and the spectrum minimum
shifted to near 208 nm (Fig. 2B). These results indi-
cated that in the presence of higher concentrations of
paclitaxel the secondary structure of insulin remained
near the native form, and little monomers converted to
ﬁbrils.
Paclitaxel inhibited the growth and lateral
aggregation ofmature insulin amyloid fibrils
In order to visualize morphological characteristics of
ﬁbrils AFM images from each sample was acquired
following incubation with or without paclitaxel.
Under experimental conditions (acidic pH and 57C)
monomers of insulin converted to ﬁbrillar insulin.
Fig. 3A shows that the insulin ﬁbrils were prominent.
In the presence of paclitaxel (50mM) the insulin ﬁbrils
were less prominent and became partially shorter and
thinner compared to no paclitaxcel (Fig. 3A). The
three micrometer scale image of each sample annex-
ation with diameter graph of ﬁbrils is depicted in
Fig. 3B. The diameter of insulin ﬁbrils which prepared
without and with paclitaxel was 104.38 3.34 nm and
57.53 5.21 nm, respectively. Also the height of ﬁbrils
on the surface of lamella was 9.16 0.86 nm and
5.71 0.57 nm in the absence and presence of pacli-
taxel, respectively. As depicted in the image, following
incubation of insulin with paclitaxel the diameter and
height of the ﬁbrils became smaller compared to ﬁbrils
formed in the absence of paclitaxel. Furthermore,
spherical shapes were observed in AFM images in
the presence of paclitaxel and imply oligomer forma-
tion (Fig. 3C). The diameter and height of oligomers
were obtained 34.87 2.06 nm and 1.75 0.11 nm,
respectively.
Fig. 1 Paclitaxel reduced insulin ﬁbrillation and delayed nucleation.
(A) Congo red absorption of insulin indicating the content of ﬁbril
formation before incubation (dashed lines) and after incubation
(dotted lines) with various concentrations of paclitaxel: 0 (ﬁlled
circle), 0.5 (times), 5 (ﬁlled diamond) and 50 (ﬁlled square) mM at pH
1.6 and 57C. Absorbance of Congo red alone is shown by the
solid line. (B) The kinetic of insulin ﬁbrillation recorded via ThT
ﬂuorescence emission at 485 nm with different concentration of
paclitaxel: 0 (open circle), 0.5 (times), 5 (open diamond) and 50
(open square) mM. (C) The elongation phase of insulin ﬁbrillation
recorded via ThT ﬂuorescence by conditions which mentioned in
previous part. Each emission point is the average of three inde-
pendent measurements, and error bars represent standard deviation
from the mean value.
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Exothermic and spontaneous interactions between
insulin and paclitaxel
The results of ITC experiment showed that the heat
exchange in the interactions of paclitaxel with insulin
was exothermic (Fig. 4). Best ﬁtting was carried out in
one set of site model, and thermodynamic parameters
were obtained for these interactions. As shown in
Table II, the number of binding sites for insulin was
1.32, the binding constant for insulinpaclitaxel inter-
action was 3.06104M1, and the heat change was
acquired as 1.13105 calM1. The entropy change
for insulin interaction was also obtained as
357 calM1K1. Thus, the extent of Gibbs free
energy was calculated as 6.2103 calM1. As these
parameters show, insulinpaclitaxel interaction is
enthalpy driven because the negative entropy is
thermodynamically unfavourable.
Diminution of salt bridges and dipolemoment in
insulin dimer
To investigate the possible interaction of paclitaxel
with insulin in monomer or aggregate form, we use
docking approaches. An ensemble of possible binding
sites in an insulin dimer molecule was generated by
using HEX. Same calculation was performed to ﬁnd
the possible effects of paclitaxel on insulin dimer for-
mation as a model to investigate the effects of pacli-
taxel on insulin aggregation. The possible salt bridges
that may appear in insulin dimer in the absence or
presence of paclitaxel are presented in Fig. 5A and B,
respectively. Paclitaxel disrupts some type of possible
salt bridges between monomers of insulin. The possible
types of salt bridges are scarce in population of insulin
dimmers in the presence of paclitaxel. To have an es-
timate of the effect of paclitaxel on polarity of insulin
dimer, the distribution of dipole moment values in in-
sulin dimer in the absence or presence of paclitaxel was
computed (Fig. 6). The population of small dipole
moment value is the speciﬁc result of paclitaxel binding
to dimer. Lower dipole support rare possibility of elec-
trostatic interactions and prove the possibility of
higher non-electrostatic (hydrophobic) interactions be-
tween insulin monomers.
Time-dependent investigation of neurite outgrowth
in PC12 cells incubatedwith insulin fibrils with or
without paclitaxel
Cell growth was determined as the following criteria:
cell body area, average neurite length and average
neurite width. Fig. 7B shows that incubation with in-
sulin ﬁbrils increased cell body area. We measured
about 1.8-fold enlargement in insulin-treated groups
without paclitaxel at 12 h compared to control. In add-
ition, insulin ﬁbrils diminished neurite length (Fig. 7C).
Paclitaxel could modulate these changes, which
occurred in cells incubated with insulin ﬁbrils without
paclitaxel. The administration of paclitaxel (50mM)
increased neurite length to 2.1-fold at 12 h compared
to insulin-treated cells at the same time. Average neur-
ite width measurement, as another criterion showed
Fig. 2 Secondary structure of insulin was stabilized by paclitaxel. Far-UV-CD spectra of insulin secondary structure: (A) before and (B) after
incubation in the presence of various concentration of paclitaxel: 0 (ﬁlled circle), 0.5 (times), 5 (ﬁlled diamond) and 50 (ﬁlled square) mM.
Table I. Kinetic parameters of insulin ﬁbrillation with different ratio concentrations of paclitaxel.
Lag phase
(min)
Lag phase
ratio
Growth rate
(min1)
Growth rate
ratio
Maximum of ThT
ﬂuorescence emission
ThT ﬂuorescence
emission ratio
Insulin 259.97 1 0.039 1 913.13 1
Paclitaxel
0.5 mM 303.82 1.16 0.072 1.86 899.10 0.98
5mM 308.40 1.18 0.047 1.22 456.95 0.50
50 mM 331.92 1.27 0.066 1.69 347.13 0.38
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insulin ﬁbrils increased neurite width, while presence of
paclitaxel prevented this effect. Neurite width was
increased by 4.9-fold in insulin ﬁbril-treated cells with-
out paclitaxel at 12 h compared to control (Fig. 7D).
Paclitaxel at 50 mM reduced this increase to 0.3-fold
compared with groups with or without paclitaxel at
the indicated time (12 h). It is worth mentioning that
the time course comparison among cell groups
Fig. 3 Paclitaxel inhibited the growth and lateral aggregation of mature insulin amyloid ﬁbrils. (A) AFM images visualizing ﬁbril structure of
insulin after incubation without or with paclitaxel (50 mM). The scale bars represent 2 mm. (B) A 3 mm scale and section proﬁle of ﬁbril images is
shown. (C) 1mm scale and section proﬁle of oligomers is shown.
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revealed that the effects of insulin ﬁbrils on PC12 cells
was worsen as time passed, especially in those without
paclitaxel administration. Fig. 7B, C and D show that
the incubation with 50 mM paclitaxel was more effect-
ive than lower concentrations of paclitaxel.
Unfavourable effects of insulin fibrils on neurite
complexity
Morphological complexity was considered based on
the number of primary neurites (410 mm), per cent of
bipolar cells and the ratio of nodes/primary neurites.
Fig. 8A shows that the number of primary neurites per
cell body was decreased in PC12 cells incubated with
insulin ﬁbrils. This reduction was modulated by the
administration of different concentrations of pacli-
taxel. However, the portion of cells with bipolar
morphology was increased in those with insulin treat-
ment. Paclitaxel application evaded this morphological
condition particularly at 50 mM (Fig. 8B). Computing
the ratio of total neurite branching nodes to total
number of primary neurites revealed that insulin ﬁbrils
could reduce this ratio to 27% of control cells at 12 h
(Fig. 8C). Paclitaxel utilization inhibited this reduction
to the most extent, i.e. the ratio was increased 3.3-fold
in paclitaxel (50 mM)-insulin PC12 cells compared with
no paclitaxel incubation (12 h). Thus, the presence of
insulin ﬁbrils decreased the morphological complexity
of PC12 cells in contrast to those incubated in the
presence of paclitaxel.
Cell viability analysis and Hoechst staining of cells
pretreatedwith insulin fibrils incubatedwith or
without paclitaxel
To determine the numbers of viable cells MTT assay
and Hoechst staining were employed after 12 h of in-
sulin ﬁbrils exposure (Fig. 9A and B). The PC12 cells
incubated with insulin ﬁbrils prepared in the presence
of paclitaxel exhibited a similar viability as control
cells, for the most part, with comparable density and
outgrowth of neurites. The MTT assay results indi-
cated that the percentage of cell viability was dimin-
ished to 37% in the presence of insulin ﬁbrils after 12 h.
However, the cell viability was maintained at an ac-
ceptable level of 63% in cells incubated with insulin
ﬁbrils prepared in the presence of paclitaxel. As
shown in Fig. 9B, Hoechst staining was also brighter
in the cells incubated with insulin ﬁbrils compared with
cells exposed to insulin ﬁbrils in the presence of pacli-
taxel. Thus, the presence of paclitaxel prevented the
morphological changes occurred in the apoptotic
cells indicated by bright blue ﬂuorescence in cells
stained with Hoechst.
Discussion
Bovine insulin is structurally similar to human insulin
(only differs by three amino acids) which is related to
the clinical syndrome injection-localized amyloidosis
(40, 41). Fibrillar deposits of insulin have been
observed in patients with type II diabetes who have
to inject insulin regularly, and as a result of aging
(9). Previous studies proposed that hydrophobic inter-
actions are key forces in driving insulin ﬁbrillation, and
were attributed to the enhanced exposure of buried
tryptophans to solvent (42). As previously demon-
strated, under acidic pH and high temperature condi-
tions insulin monomers become partially folded
intermediates (30), which provide such hydrophobic
regions for subsequent interactions and insulin
ﬁbrillation.
The results of Congo red absorbance and ThT ﬂuor-
escence studies indicated that paclitaxel had an inhibi-
tory effect on formation of beta-sheet and subsequent
ﬁbrillation of insulin (Fig. 1). The paclitaxel inhibition
was dose dependant, and increased paclitaxel concen-
trations (up to 50 mM) had a more robust inhibition.
Fig. 4 Exothermic interaction between insulin and paclitaxel. ITC
graph of insulin titrated with paclitaxel in 30 injections.
Table II. Thermodynamic parameters of insulinpaclitaxel interactions under acidic condition (pH 1.6).
Complex N K104 (M1) "H105 (cal M1) T"S105 (cal M1 K1) "G103 (cal M1)
Insulinpaclitaxel 1.32 0.379 3.06 1.35 1.133 0.518 1.07 6.2
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The AFM images (Fig. 3) conﬁrmed the reduction of
insulin ﬁbrillation in the presence of paclitaxel. In add-
ition, these images implied that the paclitaxel hindered
the lateral growth of ﬁbril by decreasing ﬁbre
diameters. The kinetic studies of insulin ﬁbrillation
showed that increased paclitaxel concentration re-
sulted in enhancement of lag phase, which indicated
that paclitaxel inhibits the ﬁbrillation process by
Fig. 5 Paclitaxel diminished salt bridges in insulin dimers. The existence of salt bridges in insulin dimers in the absence (A) or presence (B) of
paclitaxel. The X-axis indicates the possible state of the structure (frame), and the salt bridge pairs are indicated in vertical axis.
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hindering the formation of insulin seeding (nuclei).
Thus, as a result of lack of critical concentration of
insulin seeds ﬁbrillation of insulin was reduced (17).
Moreover, the elongation study of ﬁbrillation process
(Fig. 1C) implied that paclitaxel inhibits the insulin
ﬁbrillation in a nucleation-dependent manner and
does not inﬂuence elongation phase of insulin
ﬁbrillation.
In parallel to experimental proofs, computational
results indicated that paclitaxel prevents the formation
of many salt bridges in insulin dimer (Fig. 5). Thus,
paclitaxel may interfere with insulin dimer formation.
The distribution of dipole moment in insu-
linpaclitaxelinsulin structures in comparison with
insulininsulin state indicated that paclitaxel mol-
ecules cause the formation of the states with smaller
dipole moments (Fig. 6). In performed computation
experiments, we found that the insulin dimer state in
the presence of paclitaxel was more hydrophobic with
lower electrostatic interaction contents. Therefore, in
the computation phase of current study we deduced
decreasing the polarity of insulin dimer and increasing
the hydrophobicity of dimer state by paclitaxel caused
an increase in hydrophobic interaction dependent ag-
gregation phase (nucleation). However, it decreased
electrostatic-dependent interactions during elongation
of aggregation.
Fig. 7 Evaluation of Neurons by their morphological appearances using phase contrast microscopy. (A) The criteria of PC12 differentiation are
shown for three neurons from a representative image. The ‘P’ on left image indicates the primary neuritis of a neuron. The arrows show the
length of neurites, the extent of elongation and membrane-enclosed protrusions of the cytoplasm. The circle on left image shows the cell body.
The neurite width is not equal in all parts of neurons. Thus, the average neurite width was determined by dividing cell body area to average
neurite length. The white arrows point to bipolar cells. The letter ‘N’ indicates the nodes, the sites at which individual neurites branch or where
separate neurites contact each other. These criteria were quantiﬁed after different times (2, 5, 8 and 12 h) of incubation with insulin ﬁbrils. (B)
The effects of paclitaxel (0.5, 5 and 50 mM) on cell body in differentiated PC12 cells incubated with insulin ﬁbrils for different times. (C) Average
neurite length and (D) Average neurite width PC12 cells incubated with insulin ﬁbrils. Each value represents the mean S.E.M. from three
independent experiments. Asterisk denotes signiﬁcantly different from control cells. Statistical signiﬁcances were achieved when *p50.05 and
**p50.01. Hash signiﬁcantly different from insulin-treated cells at the same times when #P50.05 and ##P50.01.
Fig. 6 Paclitaxel caused the formation of insulin dimers by smaller
dipole moments. The distribution of molecular dipole moment values
of the insulin dimer state in the presence (I-L-I) or absence (I-I) of
paclitaxel. The amount of dipole moment in Deby is represented in
horizontal axis, and the frequency is indicated in per cent in Y-axis.
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Secondary structure of insulin in the presence of
paclitaxel did not have any striking changes. These
results indicated that the stabilizing effects of paclitaxel
on a-helical secondary structure of insulin were
responsible for intramolecular forces of insulin mono-
mers to remain undisrupted. Disruption of intramo-
lecular force of insulin monomers was followed by
intermolecular interactions, which resulted in its ﬁbril-
lation. Thus, paclitaxel may hinder insulin ﬁbrillation
by stabilizing such intramolecular forces.
In order to explain the interaction of paclitaxel with
insulin in acidic pH, thermodynamic studies were con-
ducted using ITC. The results of these studies indicated
that this interaction is spontaneous due to negative
value of Gibbs free energy (G). In addition, the nega-
tive value of both enthalpy change (H) and entropy
change (S) indicated a major role for van der Waal’s
interactions and hydrogen bond formation in
paclitaxelinsulin interactions (43). Theoretical and
practical studies proposed that aromatic interactions,
with a striking role for Tyr 16 of the insulin B chain.
This residue is considered to be a part of the recogni-
tion motif leading to the self-assembly of insulin (10)
with precise orientation, which is needed in this pro-
cess, and plays a signiﬁcant role in protein amyloid
self-assembly (44, 45). It has been suggested that poly-
phenols may suppress amyloid ﬁbril formation by spe-
ciﬁc aromatic interaction of aromatic residues in the
amyloidogenic sequences and their phenol rings (46).
Paclitaxel has a partially dipole conformation with hy-
droxyl, carbonyl and carboxyl substituent on one side,
and three phenol rings on the other. We presumed that
polar side of paclitaxel triggers the formation of
paclitaxelinsulin complex by hydrogen bonds, and
phenol rings play inhibitory role by pipi stacking.
Moreover, due to amide and hydroxyl groups which
are located near the phenyl rings, paclitaxel aromatic
rings are electron poor that limit the possible repulsion
between rings and reinforce pipi stacking (47).
Previous studies have shown that a beneﬁcial inhibitor
should have either recognition and inhibition/blocking
elements (10, 48). We propose that paclitaxel plays
such a remarkable role in interactions with insulin.
In our experiments differentiated PC12 cells were
utilized due to their sensitivity to neurotoxic materials
and common use as an experimental model for neuro-
toxicity (9, 33, 49). Fibrillation of insulin could induce
the deposits similar to those of Ab and t-induced
changes. These alternations could contribute to the eti-
ology of Alzheimer’s disease, and are believed to take
part in many alterations that occur in neuronal struc-
tures (50). Our data from each criterion of neurite out-
growth and complexity along with Hoechst staining
indicated that insulin ﬁbrillation decreased cell viabil-
ity. This manifestation was much apparent after longer
incubation times (8 and 12 h), when the number of bi-
polar cells with shortened length of their branches was
increased. Paclitaxel as a mitotic inhibitor stabilizes
microtubules (22), and here appeared to stabilize insu-
lin. The circular dichroism results showed that the
established neurons without any signiﬁcant morpho-
logical changes are a result of reduction in beta-sheet
formation. In agreement, our data revealed paclitaxel’s
mediatory role in preventing hallmark manifestations
of aberrant neurons. Although the current study pre-
sents a detailed analysis of the effects of different con-
centrations of paclitaxel on neuronal morphology in
insulin ﬁbril-treated PC12 cells, the involved intracel-
lular mechanisms were not determined and are subject
of future studies.
Our results showed that paclitaxel inhibited ﬁbril
formation of insulin as a protein model. Inhibition po-
tency of paclitaxel could attribute to the hindering
Fig. 8 The effects of insulin ﬁbrils (500 mM) without or with paclitaxel
(0.5, 5 and 50 mM) on neurite complexity in differentiated PC12 cells.
The indicated criteria were quantiﬁed after different times of incu-
bation (2, 5, 8 and 12 h). (A) Primary neurites per cell; (B) Percent of
bipolar cells; and (C) The ratio of nodes to primary neurites in
differentiated PC12 cells incubated with insulin ﬁbril without or with
paclitaxel. Asterisk denotes signiﬁcantly different from control cells.
Statistical signiﬁcances were achieved when *p50.05 and **p50.01.
Hash signiﬁcantly different from insulin ﬁbril-treated cells without
paclitaxel at the same times when #P50.05 and ##P50.01.
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nucleation of insulin. As indicated in results section,
spherical shapes which were observed in AFM images
in the presence of paclitaxel imply oligomer formation.
We previously showed that oligomeric forms of insulin
have neurotoxic effect on PC 12 cells (33). Here we
showed that the presence of paclitaxel reduced neuro-
toxicity of insulin ﬁbrils, although the oligomeric
forms are observable. These results support the idea
that paclitaxel causes formation of ‘off-pathway’ oligo-
mers which are nontoxic to PC12 cells (51). In add-
ition, a low dose of paclitaxel (P/I& 0.1) is sufﬁcient to
suppress insulin ﬁbrillation compared to many other
inhibitors, which are used at much higher concentra-
tions (13, 14). Finally, the utilization of paclitaxel
offers a novel strategy for designing and progression
new therapeutic agents in the treatment of diseases
related to protein conformational disorders.
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